SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas.
about
Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinasesSonic Hedgehog promotes tumor cell survival by inhibiting CDON pro-apoptotic activitySlug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancerAndrographolide targets androgen receptor pathway in castration-resistant prostate cancer.Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell linesAging impairs VEGF-mediated, androgen-dependent regulation of angiogenesismiR 488* inhibits androgen receptor expression in prostate carcinoma cellsLipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo.Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathwayRole of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase.Non-coding RNAs, epigenetic memory and the passage of information to progeny.Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer.Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticlesThe diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells.Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers.The role of transcription factors in prostate cancer and potential for future RNA interference therapy.The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivoCoordinated action of hypoxia-inducible factor-1α and β-catenin in androgen receptor signaling.The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines.Androgen deprivation causes truncation of the C-terminal region of androgen receptor in human prostate cancer LNCaP cells.The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells.Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
P2860
Q26866135-68144B5D-EE04-4030-ABDF-9CF10CF1B294Q27317023-E2BE632C-5D87-4A5C-8488-B39AC93B8044Q33636318-CBFA184C-6333-4643-8F82-75A867EAF7D2Q33968384-7FF01539-E3F7-47F7-A575-BF8E3D4C3291Q33988757-99188E7A-995C-40CC-9DCD-9BF78FC8C29EQ34131666-C55A353C-414F-4610-8F65-90D806DF6A29Q34196086-5582A80C-626C-46A2-AD7D-75DE5F4FBE34Q34233801-C9B69C03-05BD-474B-8D94-0C5185124727Q34294283-BB345D21-EE4B-4676-8739-ED6314CC0FECQ34599285-B283CB23-1EE3-4129-836F-749845002BF6Q34967058-521265F6-8FB8-4CA6-A7EC-66A816E1D743Q35269318-E1F4BE40-6BE3-4D25-A616-2E80D7D2CD9DQ35582347-D8158DAB-3EBC-4CA6-B784-D04964029F1DQ35665662-5847B872-4C4C-484B-AD4C-0E4AE7B7E749Q35823109-99DCAF52-B581-4B2B-A547-C87373E45D63Q35846835-86145BD1-E7B7-42DA-A8FA-F3BD61A70501Q37074725-B05FB907-B32D-4CFB-9485-39923CF7ABBDQ37209263-72E2DA49-6284-4124-9910-BF208020B730Q38160862-6A89F727-E3E1-48D6-972C-1C4960B80BDFQ38198726-1C7B3DE3-BD2B-469F-91A6-EC128B8BC66FQ39033044-4AAF94A1-6124-4646-BBF8-73308D4F91D4Q39143940-4FB9DBA6-44D6-4FE5-9197-B35546AACAEAQ39301953-B3C33E1A-1921-4CDD-8CB4-5950CC0A23E6Q39343181-C9FBAE06-6DB2-4F78-A8C0-9D4CDAC0EDBFQ39391441-DF1CCD10-3C1D-49C3-B3F8-D9CAC39D1B2AQ39471098-5A1BED6A-960D-49D1-85DC-344635FDD812Q41280263-D952AB83-7637-4237-81EF-1E48B3476A23
P2860
SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@ast
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@en
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@nl
type
label
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@ast
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@en
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@nl
prefLabel
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@ast
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@en
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@nl
P2093
P2860
P1433
P1476
SIRNA-directed in vivo silenci ...... resistant prostate carcinomas.
@en
P2093
Aline Bozec
Aurélie Morin
Carole Merle
Claire Mauduit
Cristèle Gilbert
Daniel Compagno
Florence Cabon
Jacques R R Mathieu
Mohammed Benahmed
P2860
P356
10.1371/JOURNAL.PONE.0001006
P407
P577
2007-10-10T00:00:00Z